Breaking News

White House digs in on ‘most-favored nation’ drug pricing

March 17, 2026
Pharmalot Columnist, Senior Writer
Andrew Harnik/Getty Images

STAT+ | White House digs in on 'most-favored nation' drug pricing despite Congress' cool reception

White House turns up pressure on lawmakers on turning voluntary MFN deals into law. 'We're gearing up for war,' White House official says.

By Daniel Payne


Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?

South Asians face greater cardiometabolic risk at lower BMI than the largely white Americans considered when determining eligibility.

By Aditi Kantipuly and Peter Singer


STAT+ | VC firm Dimension scouting out $700 million for new fund

The company, founded in 2023 by a trio of young VCs, is seeking to invest in startups melding AI and science.

By Allison DeAngelis



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments